These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27076109)

  • 21. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
    Khawcharoenporn T; Apisarnthanarak A; Mundy LM
    Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin.
    David MD; Gill MJ
    J Antimicrob Chemother; 2008 Apr; 61(4):962-4. PubMed ID: 18238890
    [No Abstract]   [Full Text] [Related]  

  • 23. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.
    Chen Z; Chen Y; Fang Y; Wang X; Chen Y; Qi Q; Huang F; Xiao X
    Sci Rep; 2015 Nov; 5():17091. PubMed ID: 26597507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B; Otük G
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
    Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
    Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
    Hsieh TC; Chen FL; Ou TY; Jean SS; Lee WS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):523-30. PubMed ID: 25442877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea.
    Park YK; Peck KR; Cheong HS; Chung DR; Song JH; Ko KS
    Emerg Infect Dis; 2009 Aug; 15(8):1325-7. PubMed ID: 19751609
    [No Abstract]   [Full Text] [Related]  

  • 33. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.
    Kim HA; Ryu SY; Seo I; Suh SI; Suh MH; Baek WK
    Microb Drug Resist; 2015 Aug; 21(4):452-7. PubMed ID: 25714496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.
    Petrosillo N; Chinello P; Proietti MF; Cecchini L; Masala M; Franchi C; Venditti M; Esposito S; Nicastri E
    Clin Microbiol Infect; 2005 Aug; 11(8):682-3. PubMed ID: 16008625
    [No Abstract]   [Full Text] [Related]  

  • 38. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
    Katragkou A; Roilides E
    J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.